Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancer
Rei Suzuki(Nishinomiya Municipal Central Hospital), Hiromasa Ohira(Fukushima Medical University), Mitsuru Sugimoto(Fukushima Medical University), Jun Nakamura(Fukushima Medical University), Naoki Konno(Fukushima Medical University), Mika Takasumi(Fukushima Medical University), Takuto Hikichi(Fukushima Medical University Hospital), Yuichi Waragai(Fukushima Medical University), Ko Watanabe(Fukushima Medical University Hospital), Hitomi Kikuchi(Fukushima Medical University), Hiroshi Watanabe, Tadayuki Takagi(Fukushima Medical University)
Cited by 50
Related Papers
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Short‐term outcomes of multicenter prospective cohort study of gastric endoscopic resection: ‘Real‐world evidence’ in Japan
|Digestive Endoscopy|2018|181
Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score
|Gut|2020|164